Essa pharma inc. (EPIX)
CashFlow / Yearly
Sep'18Sep'17Sep'16
CASH FLOWS FROM OPERATING ACTIVITIES
Loss for the year

-11,629

-4,499

-13,139

Items not affecting cash:
Amortization

34

46

66

Gain on derivative liability

151

7,305

6,574

Finance expense

911

784

910

Product development and relocation grant

229

5,192

-

Unrealized foreign exchange

19

-28

-140

Share-based payments (Note 10)

1,401

758

1,246

Loss on disposal of equipment (Note 5)

83

-

-

Changes in non-cash working capital items:
Receivables

-35

-14

48

Prepaid expenses

601

-53

644

Accounts payable and accrued liabilities

-1,120

-1,867

1,545

Income tax payable

104

-18

-91

Net cash used in operating activities

-10,218

-17,354

-15,300

CASH FLOWS FROM INVESTING ACTIVITIES
Acquisition of equipment

-

-

9

Deposits

-201

-

-

Net cash used in investing activities

-201

-

-9

CASH FLOWS FROM FINANCING ACTIVITIES
Advance on product development and relocation grant

-

5,192

3,786

Proceeds on financing

26,040

-

19,999

Share issuance costs

2,174

211

1,080

Proceeds on loan advance

-

8,000

-

Financing costs

-

220

-

Loan principal repaid

1,991

-

-

Interest paid

563

436

-

Options exercised

-

2

36

Warrants exercised

-

-

1

Net cash provided by financing activities

21,310

12,326

22,744

Effect of foreign exchange on cash

-19

0

-27

Change in cash for the year

10,871

-5,027

7,405